{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:03:56Z","timestamp":1790298236438,"version":"4.1.0"},"reference-count":86,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T00:00:00Z","timestamp":1409097600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0106337","type":"journal-article","created":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T18:03:17Z","timestamp":1409162597000},"page":"e106337","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":48,"title":["The Efficacy of Paroxetine and Placebo in Treating Anxiety and Depression: A Meta-Analysis of Change on the Hamilton Rating Scales"],"prefix":"10.1371","volume":"9","author":[{"given":"Michael A.","family":"Sugarman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy M.","family":"Loree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris B.","family":"Baltes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily R.","family":"Grekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irving","family":"Kirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,8,27]]},"reference":[{"key":"ref1","unstructured":"National Center for Health Statistics (2013) Health, United States, 2012: With special feature on emergency care. Hyattsville, MD: Centers for Disease Control and Prevention. 489 p."},{"key":"ref2","article-title":"Efficacy of drug treatments for generalised anxiety disorder: Systematic review and meta-analysis","author":"D Baldwin","year":"2011","journal-title":"BMJ"},{"key":"ref3","article-title":"The pharmacologic treatment of anxiety disorders: A review of progress","author":"LN Ravindran","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"ref4","article-title":"Evidence b(i)ased medicine\u2013selective reporting from studies sponsored by pharmaceutical industry: Review of studies in new drug applications","author":"H Melander","year":"2003","journal-title":"BMJ"},{"key":"ref5","article-title":"Selective publication of antidepressant trials and its influence on apparent efficacy","author":"EH Turner","year":"2008","journal-title":"N Engl J Med"},{"key":"ref6","unstructured":"Center for Drug Evaluation and Research (1996) Guidance for industry: Guideline for the format and content of the summary for new drug and antibiotic applications. Rockville, MD: U.S. Department of Health, Education, and Welfare. Food and Drug Administration. Available: http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/ucm072058.pdf<\/ext-link>. Accessed 31 October 2013."},{"key":"ref7","article-title":"Initial severity and antidepressant benefits: A meta-analysis of data submitted to the Food and Drug Administration","author":"I Kirsch","year":"2008","journal-title":"PLoS Med"},{"key":"ref8","article-title":"The emperor\u2019s new drugs: An analysis of antidepressant medication data submitted to the US Food and Drug Administration","author":"I Kirsch","year":"2002","journal-title":"Prevention & Treatment"},{"key":"ref9","article-title":"Listening to Prozac but hearing placebo: A meta-analysis of antidepressant medication","author":"I Kirsch","year":"1998","journal-title":"Prevention and Treatment"},{"key":"ref10","unstructured":"Harris G (2004) Maker of Paxil to release all trial results. New York: New York Times. Available: http:\/\/www.nytimes.com\/2004\/08\/26\/business\/26CND-DRUG.html<\/ext-link>. Accessed 31 October 2013."},{"key":"ref11","unstructured":"Meier B (2004) Glaxo begins posting drug trial results. New York: New York Times. Available: http:\/\/www.nytimes.com\/2004\/09\/01\/business\/01registry.html?_r=0<\/ext-link>. Accessed 31 October 2013."},{"key":"ref12","article-title":"Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: An updated meta-analysis","author":"G Gartlehner","year":"2011","journal-title":"Ann Intern Med"},{"key":"ref13","article-title":"Paroxetine in social phobia\/social anxiety disorder. Randomised, double-blind, placebo-controlled study. Paroxetine Study Group","author":"D Baldwin","year":"1999","journal-title":"Br J Psychiatry"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1176\/ajp.155.1.36","article-title":"Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder","volume":"155","author":"JC Ballenger","year":"1998","journal-title":"Am J Psychiatry"},{"key":"ref15","article-title":"A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study Investigators","author":"Y Lecrubier","year":"1997","journal-title":"Acta Psychiatr Scand"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4088\/JCP.v65n0213","article-title":"Controlled-release paroxetine in the treatment of patients with social anxiety disorder","volume":"65","author":"U Lepola","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"ref17","article-title":"A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder","author":"MR Liebowitz","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"ref18","article-title":"Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled study","author":"S Oehrberg","year":"1995","journal-title":"Br J Psychiatry"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4088\/JCP.v62n0508","article-title":"Paroxetine in the treatment of generalized anxiety disorder: Results of a placebo-controlled, flexible-dosage trial","volume":"62","author":"MH Pollack","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"ref20","article-title":"Paroxetine treatment of generalized anxiety disorder: A double-blind, placebo-controlled study","author":"K Rickels","year":"2003","journal-title":"Am J Psychiatry"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4088\/JCP.v66n0105","article-title":"Efficacy and tolerability of controlled-release paroxetine in the treatment of panic disorder","volume":"66","author":"DV Sheehan","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"ref22","article-title":"Paroxetine treatment of generalized social phobia (social anxiety disorder): A randomized controlled trial","author":"MB Stein","year":"1998","journal-title":"JAMA"},{"key":"ref23","article-title":"A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder","author":"KD Wagner","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"ref24","unstructured":"GlaxoSmithKline (2013) Paxil Medication Guide. Research Triangle Park, NC: GlaxoSmithKline. 49 p."},{"key":"ref25","article-title":"A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia","author":"K Mitte","year":"2005","journal-title":"J Affect Disord"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1176\/appi.ajp.158.12.1989","article-title":"An effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorder","volume":"158","author":"MW Otto","year":"2001","journal-title":"Am J Psychiatry"},{"key":"ref27","article-title":"A rating scale for depression","author":"M Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref28","article-title":"Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications","author":"NA Khin","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"ref29","article-title":"The assessment of anxiety states by rating","author":"M Hamilton","year":"1959","journal-title":"Br J Med Psychol"},{"key":"ref30","unstructured":"GlaxoSmithKline (2014) GSK Clinical Study Register. Brentford, UK: GlaxoSmithKline. Available: http:\/\/www.gsk-clinicalstudyregister.com<\/ext-link>. Accessed 10 February 2014."},{"key":"ref31","unstructured":"Freedom of Information Act (FOIA) (1994 & Supp. II 1996) Freedom of Information Act (FOIA). 5 US Congress. 552."},{"key":"ref32","unstructured":"Lipsey MW, Wilson DB (2001) Practical meta-analysis (applied social research methods). Thousand Oaks, CA: Sage Publications."},{"key":"ref33","article-title":"Estimation of effect size from a series of experiments involving paired comparisons","author":"RD Gibbons","year":"1993","journal-title":"Journal of Educational and Behavioral Statistics"},{"key":"ref34","unstructured":"Hedges LV, Olkin I (1985) Statistical methods for meta-analysis. New York, NY: Academic Press. 369 p."},{"key":"ref35","article-title":"Measuring inconsistency in meta-analyses","author":"JPT Higgins","year":"2003","journal-title":"BMJ"},{"key":"ref36","article-title":"Quantifying heterogeneity in a meta-analysis","author":"JP Higgins","year":"2002","journal-title":"Stat Med"},{"key":"ref37","article-title":"Meta-analysis of raw mean differences","author":"CF Bond Jr","year":"2003","journal-title":"Psychol Methods"},{"key":"ref38","article-title":"Research design features and patient characteristics associated with the outcome of antidepressant clinical trials","author":"A Khan","year":"2004","journal-title":"Am J Psychiatry"},{"key":"ref39","article-title":"Antidepressant drug effects and depression severity: A patient-level meta-analysis","author":"JC Fournier","year":"2010","journal-title":"JAMA"},{"key":"ref40","article-title":"Severe depression and antidepressants: Focus on a pooled analysis of placebo-controlled studies on agomelatine","author":"SA Montgomery","year":"2007","journal-title":"Int Clin Psychopharmacol"},{"key":"ref41","unstructured":"American Psychiatric Association Task Force for the Handbook of Psychiatric Measures (2000) Handbook of Psychiatric Measures. Washington, DC: American Psychiatric Publishing. 864 p."},{"key":"ref42","unstructured":"National Center for Health & Clinical Excellence (2010) Depression: The treatment and management of depression in adults (updated edition). London: The British Psychological Society and The Royal College of Psychiatrists. 705 p."},{"key":"ref43","unstructured":"National Institute for Clinical Excellence (2004) Depression: Management of depression in primary and secondary care. London: National Institute for Clinical Excellence. 670 p."},{"key":"ref44","article-title":"Systematic review: Placebo response in drug trials of fibromyalgia syndrome and painful peripheral diabetic neuropathy-magnitude and patient-related predictors","author":"W Hauser","year":"2011","journal-title":"Pain"},{"key":"ref45","article-title":"The placebo effect in irritable bowel syndrome trials: A meta-analysis","author":"SM Patel","year":"2005","journal-title":"Neurogastroenterol Motil"},{"key":"ref46","article-title":"A meta-analysis of the placebo response in complementary and alternative medicine trials of irritable bowel syndrome","author":"SD Dorn","year":"2007","journal-title":"Neurogastroenterol Motil"},{"key":"ref47","article-title":"The placebo response in the treatment of chronic fatigue syndrome: A systematic review and meta-analysis","author":"HJ Cho","year":"2005","journal-title":"Psychosom Med"},{"key":"ref48","article-title":"Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: A randomized trial","author":"K Kroenke","year":"2001","journal-title":"JAMA"},{"key":"ref49","article-title":"Isn\u2019t the efficacy of antidepressants clinically relevant? A critical comment on the results of the metaanalysis by Kirsch et al. 2008","author":"HJ Moller","year":"2008","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"ref50","article-title":"What does the HAMD mean","author":"S Leucht","year":"2013","journal-title":"J Affect Disord"},{"key":"ref51","first-page":"28","article-title":"The clinical global impressions scale: applying a research tool in clinical practice","volume":"4","author":"J Busner","year":"2007","journal-title":"Psychiatry (Edgmont)"},{"key":"ref52","article-title":"A meta-analysis of psychotherapy and medication in unipolar depression and dysthymia","author":"ZE Imel","year":"2008","journal-title":"J Affect Disord"},{"key":"ref53","article-title":"A systematic review of comparative efficacy of treatments and controls for depression","author":"A Khan","year":"2012","journal-title":"PLoS One"},{"key":"ref54","article-title":"Psychotherapy versus second-generation antidepressants in the treatment of depression: a meta-analysis","author":"GI Spielmans","year":"2011","journal-title":"J Nerv Ment Dis"},{"key":"ref55","article-title":"Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial","author":"DH Barlow","year":"2000","journal-title":"JAMA"},{"key":"ref56","article-title":"Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety","author":"JT Walkup","year":"2008","journal-title":"N Engl J Med"},{"key":"ref57","article-title":"Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: a meta-analytic review","author":"RK McHugh","year":"2013","journal-title":"J Clin Psychiatry"},{"key":"ref58","article-title":"Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis","author":"A Serretti","year":"2009","journal-title":"J Clin Psychopharmacol"},{"key":"ref59","first-page":"16","article-title":"Real-World Data on SSRI Antidepressant Side Effects","volume":"6","author":"E Cascade","year":"2009","journal-title":"Psychiatry (Edgmont)"},{"key":"ref60","article-title":"The serotonin syndrome","author":"EW Boyer","year":"2005","journal-title":"N Engl J Med"},{"key":"ref61","article-title":"Meta-analysis of efficacy and treatment-emergent suicidality in adults by psychiatric indication and age subgroup following initiation of paroxetine therapy: A complete set of randomized placebo-controlled trials","author":"DJ Carpenter","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"ref62","article-title":"Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration","author":"M Stone","year":"2009","journal-title":"BMJ"},{"key":"ref63","article-title":"Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial","author":"JF Rosenbaum","year":"1998","journal-title":"Biol Psychiatry"},{"key":"ref64","article-title":"Underrecognition of clinically significant side effects in depressed outpatients","author":"M Zimmerman","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"ref65","first-page":"1","article-title":"Antidepressant use in persons aged 12 and over: United States, 2005\u20132008","volume":"76","author":"LA Pratt","year":"2011","journal-title":"NCHS Data Brief"},{"key":"ref66","unstructured":"ideaPoint (2014) Clinical Study Data Request Site. Quincy, MA: ideaPoint, Inc. Available: https:\/\/clinicalstudydatarequest.com<\/ext-link>. Accessed 9 May 2014."},{"key":"ref67","article-title":"A placebo-controlled, double-blind, clinical trial of paroxetine in depressed outpatients","author":"K Rickels","year":"1989","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"ref68","first-page":"30","article-title":"The efficacy and safety of paroxetine compared with placebo in outpatients with major depression","volume":"53(Suppl)","author":"K Rickels","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"ref69","article-title":"A double-blind comparison of paroxetine and placebo in the treatment of depressed outpatients","author":"J Claghorn","year":"1992","journal-title":"Int Clin Psychopharmacol"},{"key":"ref70","first-page":"33","article-title":"The safety and efficacy of paroxetine compared with placebo in a double-blind trial of depressed outpatients","volume":"53(Suppl)","author":"JL Claghorn","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"ref71","first-page":"36","article-title":"A placebo-controlled trial of paroxetine in the treatment of major depression","volume":"53(Suppl)","author":"WT Smith","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"ref72","first-page":"27","article-title":"A double-blind, placebo-controlled study of paroxetine in depressed outpatients","volume":"53(Suppl)","author":"A Kiev","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"ref73","article-title":"Paroxetine in the treatment of depression: A comparison with imipramine and placebo","author":"JP Feighner","year":"1989","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"ref74","first-page":"44","article-title":"Paroxetine in the treatment of depression: A comparison with imipramine and placebo","volume":"53(Suppl)","author":"JP Feighner","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"ref75","first-page":"185","article-title":"A placebo- and imipramine-controlled study of paroxetine","volume":"26","author":"JB Cohn","year":"1990","journal-title":"Psychopharmacol Bull"},{"key":"ref76","first-page":"52","article-title":"Paroxetine in major depression: A double-blind trial with imipramine and placebo","volume":"53(Suppl)","author":"JB Cohn","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"ref77","first-page":"48","article-title":"A double-blind comparison of paroxetine, imipramine, and placebo in major depression","volume":"53(Suppl)","author":"RK Shrivastava","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"ref78","first-page":"267","article-title":"The short- and long-term efficacy of paroxetine HCl: A. Data from a 6-week double-blind parallel design trial vs. imipramine and placebo","volume":"25","author":"ED Peselow","year":"1989","journal-title":"Psychopharmacol Bull"},{"key":"ref79","first-page":"40","article-title":"A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatients","volume":"53(Suppl)","author":"LF Fabre","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"ref80","first-page":"21","article-title":"Optimal dose regimen for paroxetine","volume":"53(Suppl)","author":"DL Dunner","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"ref81","article-title":"A double-blind comparison of paroxetine and placebo in the treatment of depressed patients in a psychiatric outpatient clinic","author":"SM Miller","year":"1989","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"ref82","article-title":"Efficacy of paroxetine in the treatment of adolescent major depression: A randomized, controlled trial","author":"MB Keller","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref83","first-page":"176","article-title":"Efficacy and tolerability of controlled-release paroxetine","author":"RN Golden","year":"2003","journal-title":"Psychopharmacol Bull"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"577","DOI":"10.4088\/JCP.v63n0707","article-title":"Efficacy and tolerability of controlled-release and immediate-release paroxetine in the treatment of depression","volume":"63","author":"RN Golden","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.4088\/JCP.v64n0912","article-title":"Efficacy of controlled-release paroxetine in the treatment of late-life depression","volume":"64","author":"MH Rapaport","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.4088\/JCP.v65n1010","article-title":"Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder","volume":"65","author":"MH Trivedi","year":"2004","journal-title":"J Clin Psychiatry"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0106337","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T17:56:08Z","timestamp":1589046968000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0106337"}},"subtitle":[],"editor":[{"given":"Brett","family":"Thombs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,8,27]]},"references-count":86,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,8,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0106337","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,27]]}}}